TIFFANY NORTON: Open Payments
NPI 1629641139 · MADISONVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 21 payments from 9 companies in 2025. Trend: 2023 $315 · 2024 $265 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Amgen Inc. | 4 | $71 |
| Novo Nordisk Inc | 3 | $58 |
| ABBVIE INC. | 3 | $52 |
| Exact Sciences Corporation | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Dexcom, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAPLYTA, OTEZLA, Ozempic, VRAYLAR, Cologuard Collection Kit, REXULTI, Wegovy, REPATHA.
Industry payments across TN — which companies pay providers there.
